A New Risk Measurement Tool for Those at High Risk for Ovarian Cancer
https://www.facingourrisk.org/research-clinical-trials/study/236/a-new-risk-measurement-tool-for-those-at-high-risk-for-ovarian-cancer
Clinicaltrials.gov identifier:
NCT04487405 (https://clinicaltrials.gov/show/NCT04487405)
This study is using a new type of genetic test to measure ovarian cancer risk
Study Contact Information:
Contact: Tatiana Ferreira-Black by phone: 512-800-2885 or by email
About the Study
This study is using a new type of genetic test to measure ovarian cancer risk in women who have inherited gene mutations that increase their risk for ovarian cancer or women who have an ovarian cyst or a growth in the area of the ovaries or fallopian tubes (adnexal mass). This genetic test looks at seven genetic markers and then provides a score on a scale from 0 to 20 that will tell you your risk for ovarian cancer. The higher the score, the higher your risk. NOTE: This study is no longer enrolling patients.
This Study is Open To:
- Women over the age of 18 with an ovarian cyst or other mass that isn't cancer, or in follow-up due to the presence of an inherited mutation in BRCA1, BRCA2 or other gene linked to ovarian cancer risk.
- The patient reviewed, understood, and provided the study team with written informed consent to allow blood specimen to be used for research and release of medical information.
*Contact your doctor, the study coordinators or review the clinicaltrials.gov listing for a complete list of inclusion criteria.
This Study is Not Open To:
- Participant is less than 18 years of age
- Participant is not being treated in the U.S.
*Contact your doctor, the study coordinators or review the clinicaltrials.gov listing for a complete list of inclusion criteria.
About FORCE
FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.